160 related articles for article (PubMed ID: 33939475)
21. Intrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries.
Lesurtel M; Regimbeau JM; Farges O; Colombat M; Sauvanet A; Belghiti J
Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1025-7. PubMed ID: 12352225
[TBL] [Abstract][Full Text] [Related]
22. Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.
Simbolo M; Fassan M; Ruzzenente A; Mafficini A; Wood LD; Corbo V; Melisi D; Malleo G; Vicentini C; Malpeli G; Antonello D; Sperandio N; Capelli P; Tomezzoli A; Iacono C; Lawlor RT; Bassi C; Hruban RH; Guglielmi A; Tortora G; de Braud F; Scarpa A
Oncotarget; 2014 May; 5(9):2839-52. PubMed ID: 24867389
[TBL] [Abstract][Full Text] [Related]
23. Hepatobiliary and pancreatic: papillary cholangiocarcinoma.
Duong C; Martin I; Kerlin P; Clouston J; Clouston A
J Gastroenterol Hepatol; 2009 Dec; 24(12):1893. PubMed ID: 20002944
[No Abstract] [Full Text] [Related]
24. [Cholangiocarcinomas developing on multiple bile duct hamartomas syndrome].
Droy L; Sagan C; Paineau J; Gournay J; Mosnier JF
Ann Pathol; 2009 Feb; 29(1):24-7. PubMed ID: 19233090
[TBL] [Abstract][Full Text] [Related]
25. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions.
Voss JS; Holtegaard LM; Kerr SE; Fritcher EG; Roberts LR; Gores GJ; Zhang J; Highsmith WE; Halling KC; Kipp BR
Hum Pathol; 2013 Jul; 44(7):1216-22. PubMed ID: 23391413
[TBL] [Abstract][Full Text] [Related]
27. A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization.
Avadhani V; Cohen C; Siddiqui MT; Krasinskas A
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):175-179. PubMed ID: 33181516
[TBL] [Abstract][Full Text] [Related]
28. Hepatobiliary and Pancreatic: Biliary intra-epithelial neoplasia.
Ho CM; Wu CH; Liau JY
J Gastroenterol Hepatol; 2017 Aug; 32(8):1424. PubMed ID: 28752688
[No Abstract] [Full Text] [Related]
29. TTF-1 and Napsin-A are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts: continued caveats for utilization of immunohistochemistry panels.
Surrey LF; Frank R; Zhang PJ; Furth EE
Am J Surg Pathol; 2014 Feb; 38(2):224-7. PubMed ID: 24418856
[TBL] [Abstract][Full Text] [Related]
30. NIPBL::NACC1 Fusion Hepatic Carcinoma.
Hissong E; Al Assaad M; Bal M; Reed KA; Fornelli A; Levine MF; Gundem G; Semaan A; Orr CE; Sakhadeo U; Manohar J; Sigouros M; Wilkes D; Sboner A; Montgomery EA; Graham RP; Medina-Martínez JS; Robine N; Fang JM; Choi EK; Westerhoff M; Delgado-de la Mora J; Caudell P; Yantiss RK; Papaemmanuil E; Elemento O; Sigel C; Jessurun J; Mosquera JM
Am J Surg Pathol; 2024 Feb; 48(2):183-193. PubMed ID: 38047392
[TBL] [Abstract][Full Text] [Related]
31. Hidden Carcinoma: Pitfalls in the Diagnosis of Lymphoepithelioma-Like Cholangiocarcinoma.
Mostyka M; Birch MM; Samstein B; Pittman ME
Int J Surg Pathol; 2020 Dec; 28(8):872-878. PubMed ID: 32429781
[TBL] [Abstract][Full Text] [Related]
32. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma".
Braxton DR; Saxe D; Damjanov N; Stashek K; Shroff S; Morrissette JD; Tondon R; Furth EE
Hum Pathol; 2017 Apr; 62():232-241. PubMed ID: 28232156
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic procedures and results in surgical therapy for cholangiocarcinoma].
Schüle S; Altendorf-Hofmann AK; Knösel T; Uteß F; Settmacher U
Zentralbl Chir; 2014 Dec; 139 Suppl 2():e25-34. PubMed ID: 22274918
[TBL] [Abstract][Full Text] [Related]
34. Is it Possible to Increase Survival of Patients with Intrahepatic Cholangiocarcinoma? A Case Report.
Oguz S; Kucukaslan H; Topaloglu S; Ones T; Baltacioglu F; Cobanoglu U; Calik A
J Gastrointest Cancer; 2021 Mar; 52(1):342-346. PubMed ID: 32617830
[No Abstract] [Full Text] [Related]
35. An unusual mass in a cirrhotic liver.
Aepli P; Vosbeck J; Metzger J
Gastroenterology; 2012 Sep; 143(3):e12-e13. PubMed ID: 22841733
[No Abstract] [Full Text] [Related]
36. Solid-Tubulocystic Variant of Intrahepatic Cholangiocarcinoma: Report of a Pediatric Case With Molecular Characterization.
González IA; Linn RL; Wilkins BJ
Pediatr Dev Pathol; 2022; 25(6):661-667. PubMed ID: 36031872
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance cholangiography as sole pre-operative determinant of resectability in hilar cholangiocarcinoma.
Govil S; Govil S; Justus A; Korah I; Jesudason SR
Indian J Gastroenterol; 1997 Jul; 16(3):103-4. PubMed ID: 9248182
[No Abstract] [Full Text] [Related]
38. Long-term survival after curative left hepatectomy for mucin-producing cholangiocarcinoma: report of a case.
Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Otsuka N; Itoh T; Katoh H
Surg Today; 2005; 35(3):256-8. PubMed ID: 15772801
[TBL] [Abstract][Full Text] [Related]
39. Tumor-specific marker genes for intrahepatic cholangiocarcinoma: utility and mechanistic insight.
Blechacz B; Gores GJ
J Hepatol; 2008 Aug; 49(2):160-2. PubMed ID: 18538440
[No Abstract] [Full Text] [Related]
40. Genomic profiling of multifocal intrahepatic cholangiocarcinoma reveals intraindividual concordance of genetic alterations.
Lee SH; Simoneau EB; Karpinets T; Futreal PA; Zhang J; Javle M; Zhang J; Vauthey JN; Lee JS; Estrella JS; Chun YS
Carcinogenesis; 2021 Apr; 42(3):436-441. PubMed ID: 33200197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
